Literature DB >> 4619456

Clinical studies with oral clotrimazole.

H Weuta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4619456

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.

Authors:  Hui Liu; Yufeng Li; Kevin P Raisch
Journal:  Anticancer Drugs       Date:  2010-10       Impact factor: 2.248

2.  Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents.

Authors:  Miao Tian; Ming-Qing Dong; Shui-Wha Chiu; Chu-Pak Lau; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.

Authors:  T Tiffert; H Ginsburg; M Krugliak; B C Elford; V L Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 4.  Clotrimazole: a review of its antifungal activity and therapeutic efficacy.

Authors:  P R Sawyer; R N Brogden; R M Pinder; T M Speight
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.

Authors:  W H Beggs; G A Sarosi; N M Steele
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera.

Authors:  P A Rufo; D Merlin; M Riegler; M H Ferguson-Maltzman; B L Dickinson; C Brugnara; S L Alper; W I Lencer
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

7.  Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.

Authors:  C Brugnara; L de Franceschi; S L Alper
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.

Authors:  C Brugnara; B Gee; C C Armsby; S Kurth; M Sakamoto; N Rifai; S L Alper; O S Platt
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.